Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.

Pfaller, M A; Messer, S A; Georgopapadakou, N; Martell, L A; Besterman, J M; Diekema, D J

Pfaller, M A; Messer, S A; Georgopapadakou, N; Martell, L A; Besterman, J M; Diekema, D J.

Affiliation

Pfaller MA; Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, usa. michael-pfaller@uiowa.edu

J Clin Microbiol ; 47(12): 3797-804, 2009 Dec.

Article in En | MEDLINE | ID: mdl-19794038

Subject(s)

Antifungal Agents/pharmacology; Fungi/drug effects; Histone Deacetylase Inhibitors/pharmacology; Opportunistic Infections/microbiology; Triazoles/pharmacology; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fungi/classification; Humans; Microbial Sensitivity Tests; Mycoses/drug therapy; Mycoses/microbiology; Opportunistic Infections/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Opportunistic Infections / Histone Deacetylase Inhibitors / Fungi / Antifungal Agents Limits: Humans Language: En Journal: J Clin Microbiol Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google